Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MAFB |
| Upstream (Parents) |
|---|
| (<<) ETV4 → MAFB |
| (<<) NR3C1 → MAFB |
| (<<) SNAI2 → MAFB |
| (<<) PEG3 → MAFB |
| Downstream (Children) |
|---|
| MAFB → THRA (>>) |
| MAFB → ZNF135 (>>) |
| MAFB → HESX1 (>>) |
| MAFB → NR4A3 (>>) |
| MAFB → ZFPM2 (>>) |
| MAFB → MSX1 (>>) |
| MAFB → TCF4 (>>) |
| MAFB → E2F5 (>>) |
| MAFB → TRIM22 (>>) |
| MAFB → MEF2C (>>) |
| MAFB → FLI1 (>>) |
| MAFB → TLX2 (>>) |
| MAFB → ZFHX4 (>>) |
| MAFB → E2F1 (>>) |
| MAFB → TFEC (>>) |
| MAFB → HCLS1 (>>) |
| MAFB → HOXA6 (>>) |
| MAFB → HOXA3 (>>) |
| MAFB → ZNF643 (>>) |
| MAFB → ERG (>>) |
| MAFB → NR2C1 (>>) |
| MAFB → SOX17 (>>) |
